Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for Testosterone Recovery in Medically Castrated Prostate Cancer Patients
NCT07535905Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Dec 2026
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in Hypogonadism, sponsored by University Health Network. Planned start Dec 2026; status: recruiting.
02
Drugs
tamoxifen
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT07535905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07535905.